SW · GALE.SW
Galenica AG
- Sector
- Healthcare · Medical - Distribution
- Headquarters
- Bern 3027
- Website
- galenica.com
Price · as of 2024-12-31
$83.25
Market cap 4.74B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $43.25 | -48.05% |
| Intrinsic Value(DCF) | $31.84 | -61.75% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $45.99 | -44.75% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | $0.00 | $18.16 | |||
| 2016 | $0.00 | $18.67 | |||
| 2017 | $36.90 | $30.88 | $0.00 | $16.70 | $30.39 |
| 2018 | $36.34 | $25.25 | $0.00 | $0.00 | $26.73 |
| 2019 | $56.40 | $31.76 | $0.00 | $0.00 | $30.82 |
| 2020 | $50.41 | $31.93 | $0.00 | $0.00 | $45.67 |
| 2021 | $58.31 | $36.39 | $0.00 | $0.00 | $60.51 |
| 2022 | $64.33 | $38.40 | $0.00 | $0.00 | $41.60 |
| 2023 | $70.87 | $37.69 | $0.00 | $0.00 | $6.33 |
| 2024 | $79.60 | $43.25 | $0.00 | $0.00 | $45.99 |
AI valuation
Our deep-learning model estimates Galenica AG's (GALE.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $43.25
- Current price
- $83.25
- AI upside
- -48.05%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$31.84
-61.75% upside
Graham-Dodd
—
— upside
Graham Formula
$45.99
-44.75% upside
About Galenica AG
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
- CEO
- Marc Werner
- Employees
- 4.51K
- Beta
- 0.34
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($31.84 ÷ $83.25) − 1 = -61.75% (DCF, example).